Skip to main content

Third Party Logistics Provider CPGIO Uses Descartes’ Ecommerce Inventory and Order Management Solution to Achieve 5x Growth

ATLANTA, Oct. 22, 2025 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Illinois-based CPGIO, an omnichannel, optimization and fulfillment partner for consumer packaged goods (CPG) companies, is fueling explosive ecommerce growth using Descartes’ inventory and order management solution to synchronize and simplify its multichannel distribution across more than 40 sales channels. By aggregating ecommerce operations on a centralized platform, the cloud-based Descartes solution increased efficiency and visibility to enable CPGIO to scale from 2,000 to 10,000 daily orders. “With more than 600 of the world’s leading CPG brands relying on us to optimize their ecommerce operations, we needed to move beyond the constraints of our legacy...

Continue reading

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next milestone in the execution of its oncology strategy CureVac shareholders receive approximately $5.46 in BioNTech American Depositary Shares for each CureVac share, subject to a collar; an indicative exchange ratio will be available at www.envisionreports.com/CureVacOffer for the duration of the exchange offer Information on how CureVac shareholders can participate in the exchange offer is available via Georgeson LLC, the information agent for the exchange offer, at +1 888 686 7195 (toll free in the US), +1 732 353 1948 (collect), or Curevacoffer@georgeson.com Exchange offer will expire at 9:00 a.m. (New York City time) on December 3, 2025, unless extended or terminated earlier,...

Continue reading

Form 8.3 – [NCC GROUP PLC – 21 10 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree NCC GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Lulus to Report Third Quarter 2025 Results on November 12, 2025

CHICO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU), the attainable luxury brand for women, announced today that the Company will release its third quarter 2025 financial results on Wednesday, November 12, 2025, after market close. The Company will host a conference call and live webcast with the investment community at 5:00 p.m. Eastern Time that same day. The financial results and live webcast will be accessible through the Investor Relations section of the Company’s website at https://investors.lulus.com/. To access the call through a conference line, dial 1-877-407-0792 (in the U.S.) or 1-201-689-8263 (international callers). A replay of the conference call will be posted shortly after the call and will be available for seven days. To access the...

Continue reading

Mawson Infrastructure Launches GPU Pilot on Decentralized AI Network

MIDLAND. Pa. , Oct. 22, 2025 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”), a provider of digital infrastructure for artificial intelligence (AI), high-performance computing (HPC), and digital assets, has announced the launch of a graphics processing unit (GPU) pilot program on a major, leading decentralized AI network. “This initiative marks a strategic expansion for Mawson beyond digital asset mining into advanced computing such as AI and HPC,” said Kaliste Saloom, Interim Chief Executive Officer, General Counsel and Corporate Secretary at Mawson. “By leveraging our existing infrastructure, we aim to explore the opportunities which distributed networks can provide in response to the burgeoning demand for AI and HPC. Decentralized AI networks offer inroads to a ground-breaking field...

Continue reading

Mullen Group Ltd. Acquisitions Continue to Drive Growth in the Third Quarter of 2025

OKOTOKS, Alberta, Oct. 22, 2025 (GLOBE NEWSWIRE) — (TSX: MTL) Mullen Group Ltd. (“Mullen Group“, “We“, “Our” and/or the “Corporation“), one of Canada’s largest logistics providers today reported its financial and operating results for the period ended September 30, 2025, with comparisons to the same period last year.   Full details of our results may be found within our Third Quarter Interim Report, which is available on the Corporation’s issuer profile on SEDAR+ at www.sedarplus.ca or on our website at www.mullen-group.com. “Our acquisition strategy continued to drive top line growth in the quarter. This is especially satisfying given the current state of the Canadian economy, which continues to struggle with a number of trade and tariff related issues, along with...

Continue reading

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and regulatory submissions of in vitro diagnostic (IVD) assays to enable highly sensitive detection of multiple genomic markers focused on oncology applications, utilizing Bio-Rad’s Droplet Digital™ PCR (ddPCR™) technology on Bio-Rad’s QX600 platform. Following regulatory clearance, Biodesix will manufacture and distribute dedicated specimen collection kits for the developed assays. The first assays to be validated under the agreement include...

Continue reading

DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes

Strategic Alliance Targets Digital Transformation of the $634.32 Billion (1) U.S. Prescription Drug Market Through Blockchain-Enabled Data Monetization and AI-Driven Efficiency Gains BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) — via IBN — DataVault AI, Inc. (“DataVault”) (NASDAQ: DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. (“Wellgistics”) (NASDAQ: WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts (“PharmacyChain™”) into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry....

Continue reading

DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes

Strategic Alliance Targets Digital Transformation of the $634.32 Billion (1) U.S. Prescription Drug Market Through Blockchain-Enabled Data Monetization and AI-Driven Efficiency Gains BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) — via IBN — DataVault AI, Inc. (“DataVault”) (NASDAQ: DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. (“Wellgistics”) (NASDAQ: WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts (“PharmacyChain™”) into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry....

Continue reading

Atos successfully deployed its advanced sport technologies for the World Para Swimming and World Para Athletics Championships in Asia

                 Atos successfully deployed its advanced sport technologies for the World Para Swimming and World Para Athletics Championships in Asia Paris, France, October 22, 2025 – Atos, a global leader of AI-powered digital transformation, announces today it has successfully delivered the essential services for two landmark Para Sports events taking place almost simultaneously in Asia: the World Para Swimming Championships Singapore 2025, and the World Para Athletics Championships New Delhi 2025, India. Atos has been managing the planning, preparation, orchestration, and operations of both events, providing competitors and stakeholders with an exceptional experience, reinforcing the values of inclusion, accessibility and sporting excellence. The World Para Swimming Championships Singapore 2025, hosted for the first time in Asia, took...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.